Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

147.68
+1.380.94%
Post-market: 145.50-2.1800-1.48%16:51 EDT
Volume:5.08M
Turnover:750.80M
Market Cap:183.22B
PE:-56.47
High:149.30
Open:146.58
Low:146.12
Close:146.30
52wk High:157.29
52wk Low:108.46
Shares:1.24B
Float Shares:1.24B
Volume Ratio:1.05
T/O Rate:0.41%
Dividend:3.22
Dividend Rate:2.18%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.49
PE(LYR):21.78

Loading ...

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

Reuters
·
Aug 28

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

Reuters
·
Aug 28

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

TIPRANKS
·
Aug 28

US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment

Reuters
·
Aug 28

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens

THOMSON REUTERS
·
Aug 28

Moderna Inc. Stock Slips 4.6%, Underperforms Peers

Dow Jones
·
Aug 28

Moderna Inc. Stock Falls 5.8%, Underperforms Peers

Dow Jones
·
Aug 27

Gilead Sciences Updates Financial Calendar with Investor Conference Presentations

Reuters
·
Aug 27

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
Aug 26

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Dow Jones
·
Aug 25

Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus

Reuters
·
Aug 25

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Reuters
·
Aug 24

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS
·
Aug 24

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS
·
Aug 24

Funds: What a Top Biotech Fund is Buying Now

Dow Jones
·
Aug 22

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Reuters
·
Aug 22

Moderna Inc. Stock Advances 8.9%, Outperforms Peers

Dow Jones
·
Aug 22

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Reuters
·
Aug 22

Movement Alert|Gilead Sciences Rises 3.07% in Regular Trading, $7.8 Billion Arcellx Acquisition Combined with Q2 Beat Continues to Lift Shares

Market Focus
·
Aug 21